These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7717202)

  • 1. The induction of cyclooxygenase-2 elicited by endotoxin in endothelial cells and macrophages is inhibited by prostaglandin E1 and 13,14-dihydro prostaglandin E1.
    Akarasereenont P; Hide E; Ney P; Thiemermann C; Vane JR
    Agents Actions Suppl; 1995; 45():59-64. PubMed ID: 7717202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of tyrosine kinase in the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cells.
    Akarasereenont P; Mitchell JA; Appleton I; Thiemermann C; Vane JR
    Br J Pharmacol; 1994 Dec; 113(4):1522-8. PubMed ID: 7534189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide.
    Akarasereenont P; Bakhle YS; Thiemermann C; Vane JR
    Br J Pharmacol; 1995 Jun; 115(3):401-8. PubMed ID: 7582449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.
    Swierkosz TA; Mitchell JA; Warner TD; Botting RM; Vane JR
    Br J Pharmacol; 1995 Apr; 114(7):1335-42. PubMed ID: 7541688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages.
    Akarasereenont P; Mitchell JA; Bakhle YS; Thiemermann C; Vane JR
    Eur J Pharmacol; 1995 Jan; 273(1-2):121-8. PubMed ID: 7537677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prostaglandin E1 metabolites on the induction of arterial thromboresistance.
    Sinzinger H; Neumann I; O'Grady J; Rogatti W; Peskar BA
    Prostaglandins Other Lipid Mediat; 1998 Apr; 55(5-6):265-75. PubMed ID: 9653766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione mediates LPS-stimulated COX-2 expression via early transient p42/44 MAPK activation.
    Chen JX; Berry LC; Christman BW; Meyrick B
    J Cell Physiol; 2003 Oct; 197(1):86-93. PubMed ID: 12942544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
    Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.
    Mitchell JA; Akarasereenont P; Thiemermann C; Flower RJ; Vane JR
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11693-7. PubMed ID: 8265610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects.
    Cawello W; Schweer H; Müller R; Bonn R; Seyberth HW
    Eur J Clin Pharmacol; 1994; 46(3):275-7. PubMed ID: 8070511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PGE0 inhibits collagen and glycosaminoglycan-synthesis in the rabbit arterial wall.
    Rodrigues M; Sinzinger H; Kritz H; Peskar BA; O'Grady J; Rogatti W
    Vasa; 1995; 24(4):333-6. PubMed ID: 8533442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase expression in bovine aortic endothelial cells exposed to cyclic strain.
    Kito H; Yokoyama C; Inoue H; Tanabe T; Nakajima N; Sumpio BE
    Endothelium; 1998; 6(2):107-12. PubMed ID: 9930644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of prostaglandin E1 and its main plasma metabolites 15-keto-prostaglandin E0 and prostaglandin E0 by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometry.
    Schweer H; Meese CO; Watzer B; Seyberth HW
    Biol Mass Spectrom; 1994 Mar; 23(3):165-70. PubMed ID: 8148408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells.
    Inoue H; Umesono K; Nishimori T; Hirata Y; Tanabe T
    Biochem Biophys Res Commun; 1999 Jan; 254(2):292-8. PubMed ID: 9918831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation.
    Katzenschlager R; Weiss K; Rogatti W; Peskar BA; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 1992 Mar; 45(3):207-10. PubMed ID: 1589447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet, antineutrophil and vasodilating properties of 13,14-dihydro-PGE1 (PGE0)--an in vivo metabolite of PGE1 in man.
    Ney P; Braun M; Szymanski C; Bruch L; Schrör K
    Eicosanoids; 1991; 4(3):177-84. PubMed ID: 1663381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
    Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
    Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interindividual variation in the enzymatic 15-keto-reduction of 13,14-dihydro-15-keto-prostaglandin E1 in human liver and in human erythrocytes.
    Rady-Pentek P; Mueller R; Tang BK; Kalow W
    Eur J Clin Pharmacol; 1997; 52(2):147-53. PubMed ID: 9174685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of lipopolysaccharide-inducible cyclooxygenase 2 expression by C2-ceramide via c-Jun N-terminal kinase-mediated activation of CCAAT/enhancer binding protein beta in macrophages.
    Cho YH; Lee CH; Kim SG
    Mol Pharmacol; 2003 Mar; 63(3):512-23. PubMed ID: 12606757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 13,14-Dihydro-prostaglandin E1 decreases low-density lipoprotein influx into rabbit aorta.
    Sinzinger H; Virgolini I; Keiler A; Lupattelli G; Gerakakis A; Peskar BA
    Eur J Pharmacol; 1992 Aug; 219(1):129-33. PubMed ID: 1397039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.